F. Hoffmann-La Roche Ltd: FDA approves Roche's Evrysdi tablet as first and only tablet for ...
Evrysdi is the only non-invasive disease-modifying SMA treatment and is approved in over 100 countries Evrysdi tablet can be stored at room temperature and offers the same demonstrated efficacy and sa ...
manilatimes20 分钟
FDA approves Roche's Evrysdi tablet as first and only tablet for Spinal Muscular Atrophy (SMA)
Evrysdi tablet can be stored at room temperature and offers the same demonstrated efficacy and safety as the currently ...
SMA2 小时
Spinraza treatment won’t lead to kidney dysfunction, per study
Spinraza treatment does not lead to significant kidney dysfunction in SMA patients with types 1 and 2, a safety and efficacy ...
PipelineReview.com9 小时
Lineage Initiates Clinical Study of OPC1 for Spinal Cord Injury
Safety Study of Stem Cell-derived Transplant Includes Subacute and Chronic SCI Patients. CARLSBAD, CA, USA I 11, 2025 I Lineage Cell Therapeutics, Inc. (NYSE American and ...